<DOC>
	<DOCNO>NCT00688402</DOCNO>
	<brief_summary>The purpose study compare different formulation AZD3355 regard possible adverse event sensation numbness , tingling heat skin .</brief_summary>
	<brief_title>Study Compare Different Formulations AZD3355</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Lesogaberan</mesh_term>
	<criteria>Provision write informed consent Female subject childbearing potential use highly efficient contraceptive method Clinically normal physical finding Clinically significant illness within 2 week prior first dose investigational product History clinically significant disease Use prescribe medication 2 week administration first dose investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Reflux Inhibitor</keyword>
	<keyword>GERD</keyword>
	<keyword>formulation</keyword>
</DOC>